{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:01:10Z","timestamp":1791576070936,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbrc.2020.06.102","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:04:40Z","timestamp":1596067480000},"page":"922-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression"],"prefix":"10.1016","volume":"529","author":[{"given":"Juan","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.06.102_bib1","first-page":"8","article-title":"Metabolic signature of hepatic fibrosis: from individual pathways to systems biology","author":"Chang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2020.06.102_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s13071-019-3866-0","article-title":"The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis","volume":"12","author":"Chen","year":"2019","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.bbrc.2020.06.102_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cld.702","article-title":"Hepatic fibrosis: avenues of investigation and clinical implications","volume":"11","author":"Shay","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbrc.2020.06.102_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drudis.2015.10.015","article-title":"Emerging therapeutic targets for the treatment of hepatic fibrosis","volume":"21","author":"Fagone","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2020.06.102_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.yexcr.2017.02.038","article-title":"Modulation of hepatic stellate cells and reversibility of hepatic fibrosis","volume":"352","author":"Huang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2020.06.102_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41574-019-0260-0","article-title":"The clinical potential of circulating microRNAs in obesity","volume":"15","author":"Ji","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrc.2020.06.102_bib7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.06.102_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1684\/ejd.2014.2384","article-title":"Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients","volume":"24","author":"Makino","year":"2014","journal-title":"Eur. J. Dermatol."},{"issue":"6","key":"10.1016\/j.bbrc.2020.06.102_bib9","first-page":"317","article-title":"MicroRNA in localized scleroderma: a review of literature","volume":"312","author":"Wolska-Gawron","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bbrc.2020.06.102_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102396","article-title":"Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18","author":"Henry","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrc.2020.06.102_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fphar.2018.01113","article-title":"Emerging microRNA therapeutic approaches for cystic fibrosis","volume":"9","author":"Bardin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.06.102_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0125-2016","article-title":"A\u00a0systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis","volume":"26","author":"Bagnato","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bbrc.2020.06.102_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbrc.2020.06.102_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2020.06.102_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/1078-0432.CCR-16-0303","article-title":"Genetic and methylation-induced loss of miR-181a2\/181b2 within chr9q33.3 facilitates tumor growth of cervical cancer through the PIK3R3\/akt\/FoxO signaling pathway","volume":"23","author":"Mei","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.06.102_bib16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1159\/000489382","article-title":"PIK3R3 promotes metastasis of pancreatic cancer via ZEB1 induced epithelial-mesenchymal transition","volume":"46","author":"Peng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2020.06.102_bib17","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1002\/jcb.28507","article-title":"miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3\/AKT3 in uveal melanoma","volume":"120","author":"Li","year":"2019","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2020.06.102_bib18","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1038\/emm.2017.243","article-title":"PIK3R3 regulates PPARalpha expression to stimulate fatty acid beta-oxidation and decrease hepatosteatosis","volume":"50","author":"Yang","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2020.06.102_bib19","article-title":"Galectin-3, histone deacetylases, and Hedgehog signaling: possible convergent targets in schistosomiasis-induced liver fibrosis","volume":"11","author":"Fl","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.bbrc.2020.06.102_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00254","article-title":"MicroRNAs as potential targets for progressive pulmonary fibrosis","volume":"6","author":"Rajasekaran","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.06.102_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010028","article-title":"Cell-based mechanosensation, epigenetics, and non-coding RNAs in progression of cardiac fibrosis","volume":"21","author":"Ferrari","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.06.102_bib22","first-page":"8","article-title":"Mechanisms underlying hepatitis C virus-associated hepatic fibrosis","author":"Khatun","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2020.06.102_bib23","first-page":"9","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Yh","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2020.06.102_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1535370217741500","article-title":"MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice","volume":"243","author":"Huang","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2020.06.102_bib25","article-title":"MicroRNA-29a alleviates bile duct ligation exacerbation of hepatic fibrosis in mice through epigenetic control of methyltransferases","volume":"18","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.06.102_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070855","article-title":"Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective","volume":"10","author":"Farzaei","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2020.06.102_bib27","first-page":"8","article-title":"The upstream pathway of mTOR-mediated autophagy in liver diseases","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2020.06.102_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.seminoncol.2016.02.004","article-title":"The PI3K pathway: clinical inhibition in chronic lymphocytic leukemia","volume":"43","author":"Brown","year":"2016","journal-title":"Semin. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20313206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20313206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:54:09Z","timestamp":1757764449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20313206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0006291X20313206"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.06.102","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.06.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}